Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy.
Xiaoning WuJialing ZhouYameng SunHuiguo DingGuofeng ChenWen XieHongxin PiaoXiaoyuan XuWei JiangHui MaAnlin MaYongpeng ChenMingyi XuJilin ChengYouqing XuTongtong MengBingqiong WangShuyan ChenYiwen ShiYuanyuan KongXiaojuan OuHong YouJi-Dong JiaPublished in: Hepatology international (2021)
Models using on-treatment variables are more accurate than models using baseline variables in predicting LRE in patient with compensated HBV-induced cirrhosis receiving antiviral therapy. ClincialTrials.gov number NCT01943617, NCT01720238, NCT03366571, NCT02849132.